Research Study

Pilot Study to Determine Feasibility of a Randomized Trial of Screening for Coronary Artery Disease in Kidney Transplant Candidates
Principal Investigator 
John Gill

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT02082483
Status 
Closed to Recruitment
Study Start/End 
Jun 1, 2014 to Dec 31, 2017
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Jesmint Dhillon, Study Coordinator
Phone 
604-682-2344 ext.64708
Purpose of Study 

Kidney transplant candidates are at very high risk for coronary artery disease (CAD). The optimal strategy to monitor and maintain the cardiac fitness of patients awaiting kidney transplantation is unknown. Currently patients undergo annual testing; however, screening for CAD may increase morbidity and mortality by:

1.  exposing patients to the risk of angiography and revascularization procedures
2.  delaying or excluding patients from life saving transplantation.

Before proceeding with a definitive study to determine whether screening is necessary, feasibility will be determined in this pilot study.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.